Previous page

Drugs and lungs - liaisons dangereuses webinar series session five: Drug-associated pulmonary vascular disorders - 22 JANUARY, 2024

Drugs and lungs - liaisons dangereuses webinar series session five: Drug-associated pulmonary vascular disorders - 22 JANUARY, 2024

Additional content

Slides

22 January, 2024
18:00-19:00 CET

Chair: Prof. David Montani (Le Kremlin-Bicêtre, France), Prof. Katerina Antoniou (Heraklion, Greece)
Speakers: Dr Charles Khouri (Grenoble, Auvergne-Rhône-Alpes, France), Prof. David Montani (Le Kremlin-Bicêtre, France), Dr. Vinicio De Jesus Perez (Palo Alto, United States)

The Drugs and lungs - liaisons dangereuses webinar series is a seven-part programme that will take place from 26 June 2023 to 29 April 2024.

This webinar series aim to help participants develop a better understanding of the relationship between drugs and lungs. This knowledge can help them identify the signs and symptoms of drug-induced lung diseases (DILD) and provide appropriate care to patients.

Session five topics:

  • Using pulmonary arterial hypertension to demonstrate capturing pharmacovigilance signals in rare iatrogenic diseases
    Charles Khouri
  • PAH and PVOD induced by anti-neoplastic (cancer) drugs
    David Montani
  • Breaking bad: exploring the association between methamphetamine and other substance abuse and pulmonary arterial hypertension
    Vinicio de Jesus Perez

Session one: Drug-induced lung diseases (DILD) - toolbox and essentials to start with (26 June 2023)
Session two: Interstitial lung diseases - inflammation, fibrosis and oedema (4 September 2023)
Session three: Interstitial lung diseases - drugs and chemicals (23 October 2023)
Session four: DILD in cancer treatment (27 November 2023)
Session five: Drug-associated pulmonary arterial hypertension (PAH) (22 January 2024)
Session six: DILD and systemic diseases (18 March 2024)
Session seven: Respiratory injury from illicit drugs and substances (29 April 2024)